Electrophysiology – News and Features
News
Phase Forward Announces FDA Contract Award for Production Rollout of WebSDM™ with Empirica™ Study
Contract will support expanded rollout of Phase Forward’s WebSDM product with clinical trials signal detection at FDA CDER.
News
The Automation Partnership's Advanced Projects Group Announces Successful Collaboration with Cellectricon
The collaboration aims at rapidly delivering an automated ion channel screening system.
News
ERT Launches new Online Gateway to Improve Cardiac Safety in Clinical Trials
New 'My Study Portal™' is aimed at enhancing the accuracy and efficiency of cardiac safety data management in clinical trials.
News
Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
The two-year collaboration aims to enhance drug safety testing in order to bring promising therapies to patients.
News
Evotec Strengthens its Ion Channel Capabilities to Support new Alliances
Addition of ion channel focused library and additional electrophysiology equipment to support ion channel screening and medicinal chemistry alliances.
News
Exco InTouch’s ePRO Seminars Highlight Growing Importance of Electronic Communication in Clinical Trials
The informative seminars demonstrate the benefits of using electronic technology for patient recruitment, retention and compliance during clinical trials.
News
Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery
BioFocus DPI to utilize Cellectricon's Dynaflow®HT to further increase its electrophysiology-based screening capacity for fast ligand-gated ion channels.
News
ERT Launches Newly Designed Website
New improved website provides an online experience detailing information on ERT’s portfolio of clinical trial solutions, latest company news and events.
News
Nanion Opens US-office in New Jersey
Nanion expands its presence in the American market by the opening of its new headquarters to continue giving customer service.
News
Cellumen Expands Discovery Toxicology Services with Cardiac Hypertrophy Panel
Cellumen announce a new Cellular Systems Biology panel to predict cardiac hypertrophy earlier in the drug discovery and development process.
Advertisement
